MICRO LABS LTD

Overview

MICRO LABS LTD is an active pharmaceutical ingredient (API) supplier with 58 active FDA Type II Drug Master Files, covering ABROCITINIB; ACAMPROSATE CALCIUM USP; AMINOCAPROIC ACID USP; ANAGRELIDE HYDROCHLORIDE USP; APIXABAN; ARTEMETHER.

API / Drug Master Files

MICRO LABS LTD holds 58 active (59 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ABROCITINIBActive2025-06-20
• ATOGEPANTActive2025-06-13
• MAVACAMTENActive2025-05-14
• ACAMPROSATE CALCIUM USPActive2025-02-15
• LURASIDONE HYDROCHLORIDEActive2024-09-30
• BRINZOLAMIDE USPActive2024-09-30
• MIRTAZAPINE USPActive2023-09-24
• OXCARBAZEPINE USPActive2023-09-20
• PENTOSAN POLYSULFATE SODIUMActive2023-05-15
• RUFINAMIDE USPActive2023-03-23
• BEMPEDOIC ACIDActive2023-03-20
• EZETIMIBE USPActive2022-12-29
• CROMOLYN SODIUM USPActive2022-12-28
• BISOPROLOL FUMARATE USPActive2022-11-11
• PRAZIQUANTEL USPActive2022-09-30

Showing 15 of 59 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to MICRO LABS LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.